James Nam, PharmD

Most Recent Articles by James Nam, PharmD

Standard Therapy for Anal Cancer May Not Affect Long-term Outcomes Among HIV Patients

Standard Therapy for Anal Cancer May Not Affect Long-term Outcomes Among HIV Patients

By

Healthy HIV-positive patients with anal cancer are treated with standard chemoradiotherapy, but whether this patient population experiences worse outcomes or more severe toxic effects was previously unknown.

Sequence of Sunitinib and Nephrectomy May Not Affect Progression-free Rate in mRCC

Sequence of Sunitinib and Nephrectomy May Not Affect Progression-free Rate in mRCC

By

Researchers hypothesized that by reversing the order and administering targeted therapy prior to CN, tumor size would be reduced prior to surgery and lead to improved outcomes.

Prostate Cancer-specific Mortality: Relationship to Comorbidities and Treatment

Prostate Cancer-specific Mortality: Relationship to Comorbidities and Treatment

By

Researchers tracked the outcomes of 118,543 Swedish patients diagnosed with PCa over a median period of 8.3 years; patients were stratified by characteristics and treatment type.

Venetoclax Plus Rituximab May Prolong Progression-free Survival in CLL

Venetoclax Plus Rituximab May Prolong Progression-free Survival in CLL

By

Researchers randomly assigned 389 patients with R/R CLL who were previously treated with at least 1 but not more than 3 lines of therapy to receive rituximab with venetoclax or bendamustine.

Different Types of Obesity May Increase Risk of Breast Cancer Subtypes

Different Types of Obesity May Increase Risk of Breast Cancer Subtypes

By

Study results suggest that in all cases, BMI, body weight, WC, and WHR are positively correlated with breast cancer risk.

More Articles by James Nam, PharmD

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters